Ys Biopharma Co, Stock Filter Stocks by Fundamentals
YSDelisted Stock | 0.48 0.03 5.88% |
YS Biopharma Co, fundamentals help investors to digest information that contributes to YS Biopharma's financial success or failures. It also enables traders to predict the movement of YS Biopharma Stock. The fundamental analysis module provides a way to measure YS Biopharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to YS Biopharma stock.
YS Biopharma |
Did you try this?
Run Options Analysis Now
Options AnalysisAnalyze and evaluate options and option chains as a potential hedge for your portfolios |
All Next | Launch Module |
YS Biopharma Fundamentals
Return On Equity | -0.78 | |||
Return On Asset | -0.1 | |||
Profit Margin | (0.67) % | |||
Operating Margin | (0.49) % | |||
Current Valuation | 429.47 M | |||
Shares Outstanding | 188.33 M | |||
Shares Owned By Insiders | 81.42 % | |||
Shares Owned By Institutions | 2.85 % | |||
Number Of Shares Shorted | 38.89 K | |||
Price To Book | 2.10 X | |||
Price To Sales | 0.29 X | |||
Revenue | 687.2 M | |||
EBITDA | (76.82 M) | |||
Net Income | (145.48 M) | |||
Total Debt | 498.63 M | |||
Book Value Per Share | 5.10 X | |||
Cash Flow From Operations | (182.47 M) | |||
Short Ratio | 0.31 X | |||
Earnings Per Share | (0.56) X | |||
Target Price | 4.17 | |||
Number Of Employees | 773 | |||
Beta | 0.54 | |||
Market Capitalization | 192.09 M | |||
Total Asset | 1.72 B | |||
Retained Earnings | (1.87 B) | |||
Working Capital | 377.22 M | |||
Net Asset | 1.72 B |
About YS Biopharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze YS Biopharma Co,'s financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of YS Biopharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of YS Biopharma Co, based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Other Consideration for investing in YS Biopharma Stock
If you are still planning to invest in YS Biopharma Co, check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the YS Biopharma's history and understand the potential risks before investing.
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Stocks Directory Find actively traded stocks across global markets | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation |